EFLUMENIBEP ALFA
UNII S9CR2ZV5Z4

Substance Identification & Data

This profile provides standardized clinical and technical data for Eflumenibep Alfa, uniquely identified by the FDA Unique Ingredient Identifier (UNII) S9CR2ZV5Z4.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2418159-10-9 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
S9CR2ZV5Z4
CAS Registry Number
2418159-10-9
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
EFLUMENIBEP ALFA
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
National Cancer Institute reference terminology for clinical and research data.
INN ID
13610
Sequential identifier assigned via the WHO International Nonproprietary Name program.
Substance Type
protein
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Eflumenibep Alfa. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

EFLUMENIBEP ALFA

Common Names & Synonyms

EFLUMENIBEP ALFA [INN]
HUMAN SERINE PROTEASE INHIBITOR KAZAL-TYPE 2 (SPINK2, HUSI-II, ACROSIN-TRYPSIN INHIBITOR, UNIPROT: P20155) (6-66 IN THE CURRENT SEQUENCE), VARIANT(1DDDGP5>ADDED, S14>L19 , 16YRLPG20> 21WTDHQ 25, 22>E27,24HFN26> 29DYD31) FUSED AT THE C-TERMINUS TO HUMAN IMMUNOGLOBULIN G1(IGG1) FC FRAGMENT (H-CH2-CH3-CHS DOMAINS) (67-298) (HOMO SAPIENS IGHG1*03 (HINGE (67-81), CH2 (82-191), CH3 (192-296), CHS (297-298))), HOMODIMER (71-71':77-77':80-80')-TRISDISULFIDE, PRODUCED IN CHINESE HAMSTER OVARY (CHO) CELLS, GLYCOFORM ALFA

Technical Codes

DS-2325A